The weekly research desk
Latest news.
Closer reading.
A weekly selection across neuroscience, psychology and psychedelic research. Follow the original source, distinguish the study from its headline, and keep the open questions visible.
Five stories worth a closer look.
Published 19 September 2026. Three new publications and two earlier papers receiving fresh coverage. This is a selective editorial roundup, not a systematic review.
Better masking for psychedelic trials
Published 16 September 2026
Yang and colleagues argue for stronger masking in psychedelic trials. Participants’ and researchers’ guesses about treatment can complicate interpretation, making trial design an important research story in its own right.
A useful methods lens for assessing future psychedelic treatment claims.
Breathwork: expert experience is an early signal
Published 17 September 2026
A workshop study followed 48 mental-health professionals before and after high ventilation breathwork, examining their experiences and assessments of therapeutic potential and risk.
Relevant to comparisons between pharmacological and non-pharmacological altered states.
Neighbourhood disadvantage and brain health
Published 15 September 2026
A retrospective MRI study of 2,826 people associated greater neighbourhood disadvantage with an older estimated brain age. Differences for the most disadvantaged groups were approximately three years, depending on the deprivation measure.
Brings social context into discussions of brain health and individual wellbeing.
How brain hubs respond when the rules change
Paper online 6 July 2026 · News coverage 19 September 2026
Research involving 38 adults used fMRI and computational modelling to examine how frontoparietal hubs integrate information as task demands change.
A candidate for further analysis of cognitive flexibility and adaptive behaviour.
Taking LSD apart to study receptor selectivity
Paper online 8 September 2026 · News coverage 18 September 2026
Researchers examined nine simplified LSD-related compounds to investigate which molecular features contribute to receptor activity and selectivity. The work includes laboratory and mouse findings.
Useful for tracking mechanistic research separately from clinical treatment evidence.
One study can make many headlines.
The human-organoid transplantation study, Developmental xenocortication using human-derived organoids in mice, was already present in the research intake. It is therefore flagged as an existing record, not counted again as a new study.
No matching record was found for the five selected items in the repository and intake searches performed for this issue. That is a bounded search result, not a guarantee that every past discussion or external archive has been checked.
Measuring what lasts.
A new paper on validating and shortening the Persisting Effects Questionnaire may help assess positive and negative outcomes following psychedelic experiences. It remains a lead for full review; this issue makes no claim about its validation results.
Source guide · checked 19 September 2026
Where to look
for the next signal.
Discovery services help find papers. Publisher articles and trial registries are the next stop for checking what was actually studied.
Dates, sources and uncertainty stay together.
Weekly briefs are prepared on Fridays; dated issues are published following editorial review. We keep paper publication dates separate from news and indexing dates, label commentary and preclinical work, and check for existing studies before proposing integration.
This issue was collated and drafted with AI assistance under human editorial direction. No new primary data or independent replication was produced. The source guide is an editorial selection, not an endorsement of every claim on the linked websites.